Scott Ian C, Babatunde Opeyemi, Barker Christopher, Beesley Rebecca, Beesley Richard, Birkinshaw Hollie, Brooke Mel, Chaplin Hema, Chapman Lara, Ciurtin Coziana, Dale James, Dockrell Dervil, Dures Emma, Harrison Kathyrn, Jani Meghna, Lee Charlotte, McCarron Maura, Mallen Christian D, O'Connor Assie, Pidgeon Claire, Pincus Tamar, Pratt Dee, Prior Yeliz, Raza Karim, Rutter-Locher Zoe, Sharma Seema, Shaw Katie, Small Samantha, Smith Tilli, Tiffin Lesley, Tsigarides Jordan, Xenophontos Mikalena, Shenker Nicholas G
Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK.
Haywood Academic Rheumatology Centre, Midlands Partnership University NHS Foundation Trust, Staffordshire, UK.
Rheumatol Adv Pract. 2024 Nov 19;8(4):rkae128. doi: 10.1093/rap/rkae128. eCollection 2024.
Pain is a common symptom in people with inflammatory arthritis (IA), which has far-reaching impacts on their lives. Recent electronic health record studies demonstrate that UK-based pain care in people with IA commonly involves the prescribing of long-term opioids and gabapentinoids, despite an absence of trial evidence for their efficacy. Patient surveys suggest that non-pharmacological pain management is underused. A UK-specific guideline on pain management for people with IA is required to resolve this. This scoping document outlines the context and prioritized clinical questions for the first British Society for Rheumatology (BSR) guideline on pain management for people with IA. The guideline aims to provide evidence-based recommendations on how pain can be best managed in people with IA (including its assessment, and pharmacological and non-pharmacological treatments), ensuring that people with IA in the UK are offered evidence-based pain management strategies. The guideline is for healthcare professionals involved in the care of people with IA of all ages and genders, people with IA and their families and carers, NHS managers and healthcare commissioners, and other relevant stakeholders such as patient organizations. It will be developed using the methods outlined in the BSR's 'Creating Clinical Guidelines' protocol.
疼痛是炎症性关节炎（IA）患者的常见症状，对他们的生活有着深远影响。最近的电子健康记录研究表明，在英国，IA患者的疼痛护理通常涉及长期开具阿片类药物和加巴喷丁类药物，尽管缺乏关于其疗效的试验证据。患者调查显示，非药物疼痛管理的使用不足。因此需要一份针对英国IA患者疼痛管理的特定指南来解决这一问题。本范围界定文件概述了首个英国风湿病学会（BSR）关于IA患者疼痛管理指南的背景和优先临床问题。该指南旨在就如何最佳管理IA患者的疼痛（包括疼痛评估以及药物和非药物治疗）提供循证建议，确保为英国的IA患者提供循证疼痛管理策略。该指南适用于参与各年龄段和性别的IA患者护理的医疗专业人员、IA患者及其家人和护理人员、国民保健服务（NHS）管理人员和医疗保健专员，以及患者组织等其他相关利益攸关方。它将采用BSR“制定临床指南”方案中概述的方法来制定。
